Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”

키워드

참고문헌 (12)

1. Lilian Yan Liang, "Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers", Clinical and Molecular Hepatology, 29(1), pp.113~117 (2023), 대한간학회
2. Lung-Yi Mak, "Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B", Clinical and Molecular Hepatology, 29(1), pp.146~162 (2023), 대한간학회
3. Sun Woong Kim, "Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus", Clinical and Molecular Hepatology, 28(1), pp.17~30 (2022), 대한간학회[DOI]
4. Cornberg M, "Guidance for design and endpoints of clinical trials in chronic hepatitis B-report from the 2019 EASL-AASLD HBV treatment endpoints conference", Hepatology, 71, pp.1070~1092 (2020)
5. Yuen MF, "Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB", J Hepatol, 77, pp.1287~1298 (2022)
6. Yuen MF, "Efficacy and safety of bepirovirsen in chronic hepatitis B infection", N Engl J Med, 387, pp.1957~1968 (2022)
7. Cornberg M, "AASLD-EASL HBV Endpoints 2022", ~ (2022)
8. Berg T, "The times they are a-changing-a refined proposal for finite HBV nucleos(t)ide analogue therapy", J Hepatol, 75, pp.474~480 (2021)
9. Takako Inoue, "Novel biomarkers for the management of chronic hepatitis B", Clinical and Molecular Hepatology, 26(3), pp.261~279 (2020), 대한간학회[DOI]
10. Fan R, "Combining hepatitis B virus RNA and hepatitis B core-related antigen : guidance for safely stopping nucleos(t)ide analogues in hepatitis B e antigen-positive patients with chronic hepatitis B", J Infect Dis, 222, pp.611~618 (2020)
11. Papatheodoridi M, "Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapy", J Viral Hepat, 29, pp.948~957 (2022)
12. European Association for the Study of the Liver, "EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection", J Hepatol, 67, pp.370~398 (2017)

관련 논문AI추천